Evidence map›Paper›PMID 34463941›Full record

ArticlePituitary2022

Typing of inflammatory lesions of the pituitary.

J Warmbier, D K Lüdecke, J Flitsch, M Buchfelder, R Fahlbusch, U J Knappe, J Kreutzer, R Buslei, M Bergmann, F Heppner and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Pituitary, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Immune-Mediated Hypophysitis: An Updated Review.Journal of clinical medicine · 2026
    Review
  3. Article
  4. Mimickers of pituitary tumors.Neuro-oncology advances · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Multiple tumorous lesions of the pituitary gland.Hormones (Athens, Greece) · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

J WarmbierInstitute of Neuropathology of the University of Hamburg, UKE, 20246, Hamburg, Germany.
D K LüdeckeClinic of Neurosurgery of the University of Hamburg, UKE, 20246, Hamburg, Germany.
J FlitschClinic of Neurosurgery of the University of Hamburg, UKE, 20246, Hamburg, Germany.
M BuchfelderClinic of Neurosurgery, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
R FahlbuschInternational Neuroscience Institute (INI), Rudolf-Pichelmayr-Str. 4, 30625, Hannover, Germany.
U J KnappeDepartment of Neurosurgery, Johannes-Wesling-Klinikum Minden, Ruhr-University Bochum (RUB), 32429, Minden, Germany.
J KreutzerPraxis for Neurosurgery, 90941, Nuremberg, Germany.
R BusleiInstitute of Pathology, SozialStiftung Bamberg, 96049, Bamberg, Germany.
M BergmannInstitute of Neuropathology, Klinikum Bremen-Mitte, 28205, Bremen, Germany.
F HeppnerInstitute of Neuropathology of the Humboldt University of Berlin, Charitè, 10117, Berlin, Germany.
M GlatzelInstitute of Neuropathology of the University of Hamburg, UKE, 20246, Hamburg, Germany.
W SaegerInstitute of Neuropathology of the University of Hamburg, UKE, 20246, Hamburg, Germany. w.saeger@uke.de.ORCID http://orcid.org/0000-0003-3340-8523
Universität Hamburg · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHumboldt-Universität zu Berlin · DEInternational Neuroscience Institute · DEJohannes Wesling Klinikum Minden · DEKlinikum Bremen-Mitte · DEOrthopädische Praxis · DESozialstiftung Bamberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory pituitary lesions account for 1.8% of all specimens from the German Pituitary Tumor Registry. They occure in 0.5% of the autoptical specimens and in 2.2% of the surgical cases. Women are significantly more often affected than men and are often younger when first diagnosed. In general, primary and secondary inflammation can be distinguished, with secondary types occurring more frequently (75.1%) than idiopathic inflammatory lesions (15.4%). In primary inflammation, the lymphocytic type is more common (88.5%) than the granulomatous type of hypophysitis (11.5%). The most common causes of secondary inflammation are Rathke's cleft cysts (48.6%), followed by tumors (17.4%) such as the craniopharyngioma (9.1%), adenoma (5.5%) or germinoma (2.0%). More causes are tumor-like lesions (7.1%) such as xanthogranuloma (3.5%) or Langerhans histiocytosis (3.5%), abscesses (5.5%), generalized infections (5.1%), spreaded inflammations (4.7%) and previous surgeries (4.0%). In 1.6% of all specimens the reason for the inflammation remains unclear. The described classification of hypophysitis is important for specific treatment planning after surgery.

Indexed as

Central Nervous System CystsCraniopharyngiomaPituitary DiseasesPituitary NeoplasmsFemaleHumansMalePituitary GlandClassificationHypophysitisPathologyPituitary

Identifiers

PMID34463941
PMCPMC8821060
OpenAlexW3198538422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.